Call Today: (800) 729-9072
Submit your Defective Drugs claim details for a free, no obligation case review
Get Started:
The recently recalled Digitek is particularly risky to kidney failure patients (individuals in whom one or both kidneys have failed to function to some degree). Digitek treatment of a kidney failure patient can result in very serious adverse events and even death.
Digitek is the brand name of a digitalis-based heart medication manufactured by the pharmaceutical company Actavis. All Digitek in the U.S. was recalled in the spring of 2008 due to a grave mistake in the manufacturing process: some of the Digitek tablets contain twice the correct amount of the active ingredient, digoxin. This doubled level of digoxin is dangerous enough to people with healthy kidneys, and Digitek’s danger is greater still for individuals whose kidney failure won’t adequately remove the digoxin from the body.
Indeed, both kidney disease and liver disease can increase the effects of Digitek because they result in a slower removal of the medicine from the body. The symptoms of Digitek/digitalis toxicity in a kidney failure patient include:
If you are a kidney failure patient who has been harmed by Digitek, it’s important for you to know your legal rights. Damages, costs, and other losses caused by Digitek may be eligible for financial compensation from defendants such as the drug’s maker.
Damages that are typically compensated include medical bills and loss of income. Contact a Digitek attorney today to discuss your case and explore your legal options.
According to recent reports, Actavis Totowa, the makers of Digitek, have recalled all generic drugs manufactured at their New Jersey plant.
...
At least nine lawsuits have been filed in a New Jersey federal court in the wake of an April 2008 recall of Digitek, a prescription drug used in ...